Citizens JMP analyst Aaron Kimson raised the firm’s price target on Phreesia (PHR) to $34 from $30 and keeps an Outperform rating on the shares. Phreesia announced better than expected Q2 results and the acquisition of AccessOne for $160M, the analyst tells investors in a research note. The firm believes the AccessOne acquisition is a logical strategic fit that will help Phreesia expand its existing payments business, and thinks the acquisition should be accretive to adjusted EBITDA margins once closed.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PHR:
- Phreesia’s Strategic Gamble: Navigating Risks and Delays in the AccessOne Acquisition
- Phreesia’s Positive Earnings Call Highlights Strategic Growth
- Phreesia price target raised to $36 from $35 at Truist
- Phreesia’s Strong Financial Performance and Strategic Growth Initiatives Drive Buy Rating
- Phreesia price target raised to $33 from $30 at Raymond James